Quick Answer
OPKO HEALTH, INC. reported R&D Expense of $124.03 million for fiscal year 2025.
OPKO HEALTH, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $124.03M | +17.9% |
| 2024 | $105.21M | +17.4% |
| 2023 | $89.59M | +21.3% |
| 2022 | $73.89M | -3.9% |
| 2021 | $76.85M | +2.0% |
| 2020 | $75.32M | -36.1% |
| 2019 | $117.87M | -6.1% |
| 2018 | $125.59M | -0.7% |
| 2017 | $126.44M | +11.0% |
| 2016 | $113.87M | +14.5% |
| 2015 | $99.49M | +19.0% |
| 2014 | $83.57M | +55.0% |
| 2013 | $53.90M | +176.1% |
| 2012 | $19.52M | +72.0% |
| 2011 | $11.35M | +90.8% |
| 2010 | $5.95M | -45.1% |
| 2009 | $10.84M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $30.08M | +4.5% | -0.9% |
| June 30, 2025 | $30.34M | +26.0% | -1.6% |
| March 31, 2025 | $30.84M | +40.6% | +7.2% |
| September 30, 2024 | $28.77M | +48.0% | +19.5% |
| June 30, 2024 | $24.08M | +32.6% | +9.8% |
| March 31, 2024 | $21.94M | -32.7% | +12.9% |
| September 30, 2023 | $19.43M | +3.4% | +7.0% |
| June 30, 2023 | $18.16M | +5.2% | -44.3% |
- OPKO HEALTH, INC. showed an increase of +17.9% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2025 period, OPKO HEALTH, INC.’s r&d expense has grown by 1044.6% (from $10.84 million to $124.03 million).
- The most recent figure is from OPKO HEALTH, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: